The store will not work correctly when cookies are disabled.
2-(Hydroxyethylamino)-8,9-dihydro-5H-[1,3]dioxolo[4,5]benzo[1,2-d][1,3]diazepine
ID: ALA3986826
PubChem CID: 134156245
Max Phase: Preclinical
Molecular Formula: C12H15N3O3
Molecular Weight: 249.27
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: OCCNC1=NCCc2cc3c(cc2N1)OCO3
Standard InChI: InChI=1S/C12H15N3O3/c16-4-3-14-12-13-2-1-8-5-10-11(18-7-17-10)6-9(8)15-12/h5-6,16H,1-4,7H2,(H2,13,14,15)
Standard InChI Key: AYQFKASUJPEFFG-UHFFFAOYSA-N
Molfile:
RDKit 2D
18 20 0 0 0 0 0 0 0 0999 V2000
19.1088 -9.6976 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.9147 -9.5111 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.2695 -8.7684 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.9147 -8.0257 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.1088 -7.8434 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4650 -8.3560 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4650 -9.1808 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7493 -7.9437 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7493 -9.5932 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4272 -10.1590 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.2422 -10.0353 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.5447 -9.2677 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.3596 -9.1440 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.0336 -9.1808 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0336 -8.3572 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2502 -8.1026 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.7661 -8.7690 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2503 -9.4353 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 1 0
5 6 1 0
6 7 1 0
1 7 1 0
8 15 1 0
14 9 1 0
7 9 2 0
6 8 2 0
11 12 1 0
10 11 1 0
12 13 1 0
2 10 1 0
14 15 2 0
15 16 1 0
16 17 1 0
17 18 1 0
18 14 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 249.27 | Molecular Weight (Monoisotopic): 249.1113 | AlogP: 0.32 | #Rotatable Bonds: 2 |
Polar Surface Area: 75.11 | Molecular Species: BASE | HBA: 6 | HBD: 3 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 9.40 | CX LogP: 0.42 | CX LogD: -1.44 |
Aromatic Rings: 1 | Heavy Atoms: 18 | QED Weighted: 0.70 | Np Likeness Score: 0.39 |
References
1. McMullan M, García-Bea A, Miranda-Azpiazu P, Callado LF, Rozas I.. (2016) Substituted conformationally restricted guanidine derivatives: Probing the α2-adrenoceptors' binding pocket., 123 [PMID:27474922] [10.1016/j.ejmech.2016.07.011] |